treatment protocols – Page 3 – Communicable Diseases Research

Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study

터키 사카리아의 코로나19 중증환자의 특성 및 결과: 단일 센터 코호트 연구

Article

Published on 2021-04-302022-09-10
Journal: Turkish Journal of Medical Sciences
[Category] MERS, SARS, 치료제,

Geographic Factors Associated with Poorer Outcomes in Patients Diagnosed with COVID-19 in Primary Health Care

Article

Published on 2021-04-062022-10-29
Journal: International Journal of Environmental Research an
[Category] COVID-19, MERS, SARS,

Focused role of nanoparticles against COVID-19: Diagnosis and treatment

Review

Published on 2021-04-062023-06-15
Journal: Photodiagnosis and photodynamic therapy
[Category] MERS, SARS,

[키워드] 2019-nCoV, severe acute respiratory syndrome coronavirus 2 Ag-MES, silver nanoparticle capped with mercaptoethane sulfonate AMT, 4′-aminomethyl-trioxsalene ARDS, acute respiratory distress syndrome AuNP-ab, gold-antibody nanoparticle BAL, bronchoalveolar lavage cDNA, complementary DNA COVID-19 COVID-19, coronavirus disease CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats CT, Computed tomography Diagnosis EHEC, enterohemorrhagic Escherichia coli ELISA, enzyme-linked immunosorbent assay ergic, endoplasmic reticulum-golgi intermediate compartment EUA, Emergency Use Authorization FDA, Food and Drug Administration FISH, fluorescent in situ hybridization G-CSF, (Granulocyte colony-stimulating facto) GQD, graphene quantum dot GSH, glutathione HBV, hepatitis B virus HCV, hepatitis C virus HIV, Human immunodeficiency virus HSV-1, herpes Simplex type-1 virus IC, inhibitory concentration ICU, Intensive Care Units IFN-γ, interferon gamma IGG, immunoglobulin g IGM, immunoglobulin m IP10, 10 Kda interferon gamma-induced protein LAMP, Loop-mediated isothermal amplification MagLev, magnetic levitation MB, methylene blue MCP1, monocyte chemoattractant protein-1 MERS-CoV, Middle East respiratory syndrome coronavirus MHV-A59, mouse coronavirus MWCNTs, multi-walled carbon nanotubes NagC, nano-silver colloids nanomedicine Nanoparticles PCR, polymerase chain reaction PDI, photodynamic inactivation PDT, photodynamic therapy PICALM, phosphatidylinositol binding clathrin assembly protein PS, photosensitizer PTAF, photocatalytic titanium apatite filter RCA, rolling circle amplification RdRp, RNA-dependent RNA polymerase RNA, Ribonucleic acid ROS, reactive oxygen species RPA, recombinase polymerase amplification RT-PCR, Reverse transcription polymerase chain reaction SARS-CoV, severe acute respiratory syndrome coronavirus SPION, superparamagnetic iron oxide nanoparticles Th2, T-helper-2 TNFα, Tumor necrosis factor alpha TPPS2a, tetraphenyl porphyrin disulphonate treatment protocols USFDA, United States Food And Drug Administration UV, ultraviolet WHO, World Health Organization
[DOI] 10.1016/j.pdpdt.2021.102287 PMC 바로가기 [Article Type] Review

Distinguishing active pediatric COVID-19 pneumonia from MIS-C

Research Article

Published on 2021-02-242022-10-29
Journal: Pediatric Rheumatology Online Journal
[Category] COVID-19, MERS,

[키워드] Accuracy Admission baseline black C-reactive protein center change Characteristics clinical note Control COVID-19 COVID-19 patient COVID-19 patients defined demographics diagnosed Diagnosis diagnostic disease distinguishing electronic medical record erythrocyte sedimentation rate finding Gastrointestinal symptom group health-care healthy Hispanic patient Hospitalized Importance Laboratory laboratory data lactate dehydrogenase male Mild MIS-C Moderate COVID-19 MOST objective Patient PCR pediatric Pneumonia positive predominant presenting procalcitonin prodrome Rash Respiratory Support respiratory symptoms SAR-CoV-2 severe COVID-19 significant difference sodium levels Symptom symptomatic Symptoms the SARS-CoV-2 virus Treatment treatment protocols two group
[DOI] 10.1186/s12969-021-00508-2 PMC 바로가기 [Article Type] Research Article

High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration

경미한 형태의 COVID-19 환자의 비인두에서 높은 SARS-CoV-2 로드는 하이드록시클로로퀸 투여와 상관없이 임상 악화와 관련이 있습니다

Research Article

Published on 2021-01-292022-09-12
Journal: PLoS ONE
[Category] MERS, 진단,

[키워드] Anti-SARS-CoV-2 Activity Antiviral approved Arterial hypertension Clinical data Clinical deterioration clinically control group country COVID-19 COVID-19 infection COVID-19 infections deaths Deterioration disease dose drug evaluated Federation framework HCQ HCQ therapy Hydroxychloroquine hydroxychloroquine administration hypertension in vitro in vivo infected patient infected patients Medical conditions Mild Ministry of Health nasopharynx non-randomized observational study Pathologies Patient people with COVID-19 per day pharmacological Prophylaxis receiving reduced risk factor RNA Russia SARS-CoV-2 SARS-CoV-2 RNA shown statistically significant Support Swab Symptom the SARS-CoV-2 therapy treatment instructions Treatment protocol treatment protocols Viral viral RNA load viral shedding virus RNA while
[DOI] 10.1371/journal.pone.0246396 PMC 바로가기 [Article Type] Research Article

External validation of multimodal termination of resuscitation rules for out-of-hospital cardiac arrest patients in the COVID-19 era

COVID-19 시대 병원 밖 심정지 환자에 대한 소생 규칙의 다중 모드 종료 외부 검증

Observational Study

Published on 2021-01-272022-09-12
Journal: Scandinavian Journal of Trauma, Resuscitation and
[Category] 임상, 진단,

[키워드] 95% confidence interval ALS applied Asian asystole Basic Life Support Cardiac arrest Cardiopulmonary resuscitation circulation collected Combination coronavirus coronavirus disease Coronavirus Disease (COVID)-19 COVID-19 COVID-19 patient COVID-19 patients criteria Culture cultures diagnostic disease transmission eligible Emergency medical technicians Ethics etiology evaluate evaluated External external validation Factor False positive feasibility FPV Heart arrest hospital discharge International lead life limit multicenter observational study nine North America observational study one patient outcome outcomes Patient patient survival Positive predictive value PPV Predictive value presenting Prognosis regions registry data Research resource Result Resuscitation return risk sensitivity Shock specificity subject supplementary material Support survival survived termination Transport Treatment protocol treatment protocols Variation variations
[DOI] 10.1186/s13049-021-00834-0 PMC 바로가기 [Article Type] Observational Study

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2

Microbiology

Published on 2021-01-252022-10-31
Journal: Frontiers in Microbiology
[Category] COVID-19,

[키워드] ACE-2 ACE-2 receptor addition Against Antiviral antiviral agent bind cause caused Cell Chloroquine chloroquine/hydroxychloroquine clinical trial conducted Consequences coronavirus coronavirus disease COVID-19 docking drug drugs evaluated Favipiravir global pandemic Hydroxychloroquine inhibitors of SARS-CoV-2 Ivermectin M protein mechanism membrane fusion Membrane proteins molecular dynamics nsp14 Potential Proteases RdRP Remdesivir remdesivir (GS-5734) Replication reported Repurposed drugs Respiratory disease RNA RNA polymerase SARS-CoV-2 screened severity Stage surface receptor target target proteins the binding affinity therapeutic agents TMPRSS2 treatment protocols Trigger viral replication viral spike protein was performed Wuhan
[DOI] 10.3389/fmicb.2020.592908 PMC 바로가기 [Article Type] Microbiology

Influence of aluminum salts on COVID-19 infected patients

COVID-19 감염 환자에 대한 알루미늄 염의 영향

Observational Study

Published on 2020-12-172022-09-10
Journal: Turkish Journal of Medical Sciences
[Category] MERS, SARS, 임상, 치료제,

[키워드] addition alum aluminum aluminum salts analysis Antiviral Chain Reaction clinical Clinical findings Comorbidity Control control group Coronavirus (COVID-19) COVID-19 COVID-19 infected patient COVID-19 infected patients CRP level CRP levels diagnosed discharge drop Effect examined Follow-up group Hospital stay Hospitalization include infected cases infected patients Infectious disease influence intake intensive care Laboratory parameters Lactate lactate dehydrogenase LDH material mechanical ventilation not achieved oral intake pandemic patients PCR performed Pneumonia polymerase chain polymerase chain reaction procalcitonin procalcitonin level radiological Recovery time recovery times Result retrospective cohort study salt salts Side effect Side effects significantly significantly shorter survival Symptom Symptoms the patient Toxicity Treatment treatment group Treatment protocol treatment protocols two group two groups
[DOI] 10.3906/sag-2009-140 PMC 바로가기 [Article Type] Observational Study

The role of dysregulated immune responses in COVID-19 pathogenesis

Review

Published on 2020-10-162022-10-04
Journal: Virus research
[Category] MERS, SARS, 진단,

[키워드] acute respiratory distress Adults appear ARDS caused children clinical manifestation Complication Consequences coronavirus COVID-19 COVID-19 pathogenesis Critical difference disorder dysregulated immune response global public health Host immune dysregulation immune regulation immune response immune system immunocompetent cell Immunopathogenesis Impaired IMPROVE Infant infections Inflammation Local lung Mild pandemic pathogenesis of COVID-19 recognizing reduction in Research SARS-CoV-2 SARS-COV-2 infection severe COVID-19 disease severity of COVID-19 Spread syndrome systemic immune response treatment protocols virus
[DOI] 10.1016/j.virusres.2020.198197 PMC 바로가기 [Article Type] Review

The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

입원한 COVID-19 환자의 결과 개선에 대한 파모티딘의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-10-132022-08-13
Journal: Trials
[Category] MERS, SARS, 임상,

[키워드] Alanine Alanine transaminase alcoholism All participant All participants allergies allergy allocation approved ARMS aspartate Aspartate transaminase assigned assumption Bandar Abba Bandar Abbas baseline Blinding block randomization blood count Care Chronic kidney disease clearance clinical clinical trial clinical trials code Committee company comparator Comparator group complete blood count concealed control group control groups COVID-19 COVID-19 patient COVID-19 patients creatinine creatinine clearance criteria Dasatinib dialysis discharge dissemination dosage drug therapy electrocardiogram element eligibility criteria End-stage renal disease ethics committee Evidence evidence of excluded expected Famotidine G6PD Glucose Glucose 6 phosphate grouping groups Hepatitis hepatitis C Hospitalized Immunocompromised Immunocompromised patients Infection Intervention Kidney disease Lactate lactate dehydrogenase lead limit Liver disease Local lung infiltration maximum Medical Science Medical Sciences moderate need for dialysis Neratinib normal limit number objective online tool oral contraceptives outcome outcome assessor outcome assessors oxygen oxygen saturation Ozanimod participant Patient patients patients with COVID-19 Pazopanib PCR test pharmaceutical Pharmaceutical Company phosphate Placebo placebo-controlled porphyria positive Pregnancy protocol psoriasis random randomisation randomised randomised controlled trial randomized clinical trial Randomly randomly divided receive recruitment Registered registry renal renal disease renal failure reported Research question researcher respiration rate responsible Rilpivirine Sample size sample size calculation sequence sequence information single-blind Siponimod Standard study drug Study protocol subject submitted technology temperature the ethics committee therapy title Tizanidine transaminase Treatment treatment group Treatment protocol treatment protocols Trial registration two group two groups university Version website were measured written consent
[DOI] 10.1186/s13063-020-04773-6 PMC 바로가기 [Article Type] Letter